The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 5,701–5,800 of 31,469
Glycemic control is impaired in the evening in prediabetes through multiple diurnal rhythms
Sonnier, T. J., Rood, J., Gimble, J. M., & Peterson, C. M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.04.001 · Cited by 62
Murri, M., García‐Fuentes, E., García‐Almeida, J. M., Garrido‐Sánchez, L., Mayas, M. D., Bernal, R., & Tinahones, F. J. (2009) · Obesity Surgery · doi:10.1007/s11695-009-0021-6 · Cited by 62
Screening for Cushing’s Syndrome in Obese Patients
Tiryakioğlu, Ö., Uğurlu, S., Yalın, S., Yirmibeşçik, S., Çağlar, E., Yetkin, D. Ö., & Kadıoğlu, P. (2010) · Clinics · doi:10.1590/s1807-59322010000100003 · Cited by 63
Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass
Culnan, D. M., Cooney, R. N., Stanley, B. A., & Lynch, C. J. (2008) · Obesity · doi:10.1038/oby.2008.428 · Cited by 64
Significance of acanthosis nigricans in childhood obesity
Güran, T., Turan, S., Akçay, T., & Bereket, A. (2008) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.01272.x · Cited by 62
A Systems Model for Immune Cell Interactions Unravels the Mechanism of Inflammation in Human Skin
Valeyev, N. V., Hundhausen, C., Umezawa, Y., Kotov, N. V., Williams, G. H., Clop, A., Ainali, C., Ouzounis, C. A., Tsoka, S., & Nestle, F. O. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001024 · Cited by 62
Lai, M.-H., Chen, Y., Chen, Y.-Y., Chang, J.-H., & Cheng, H.-H. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-87 · Cited by 62
Waist circumference is related to low-grade inflammation in youth
Steene-Johannessen, J., Kolle, E., Reseland, J. E., Anderssen, S. A., & Andersen, L. B. (2010) · International Journal of Pediatric Obesity · doi:10.3109/17477160903497035 · Cited by 62
Effect of the glycemic index of carbohydrates on acne vulgaris
Reynolds, R. C., Lee, S., Choi, J. Y. J., Atkinson, F. S., Stockmann, K. S., Petocz, P., & Brand-Miller, J. C. (2010) · Nutrients · doi:10.3390/nu2101060 · Cited by 64
Relationship between leptin and body mass and metabolic syndrome in an adult population
Martins, M. D. C., Faleiro, L. L., & Fonseca, A. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.09.008 · Cited by 62
Schliep, K. C., Schisterman, E. F., Mumford, S. L., Pollack, A. Z., Zhang, C., Ye, A., Stanford, J. B., Hammoud, A. O., Porucznik, C. A., & Wactawski‐Wende, J. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.021287 · Cited by 62
Alvarez, J. A., Ashraf, A. P., Hunter, G. R., & Gower, B. A. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.000976 · Cited by 63
Masquio, D. C. L., de Piano, A., Sanches, P. D. L., Corgosinho, F. C., Campos, R. M. D. S., Carnier, J., da Silva, P. L., Caranti, D. A., Tock, L., Oyama, L. M., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04504.x · Cited by 62
Preventive effects of North American ginseng (Panax quinquefolium) on diabetic nephropathy
Sen, S., Chen, S., Feng, B., Wu, Y., Lui, E. M. K., & Chakrabarti, S. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.01.001 · Cited by 62
Vázquez‐Medina, J. P., Popovich, I. Y., Thorwald, M. A., Viscarra, J. A., Rodríguez, R., Soñanez‐Organis, J. G., Lam, L., Peti‐Peterdi, J., Nakano, D., Nishiyama, A., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00101.2013 · Cited by 63
Hayaishi-Okano, R., Yamasaki, Y., Kajimoto, Y., Sakamoto, K., Ohtoshi, K., Katakami, N., Kawamori, D., Miyatsuka, T., Hatazaki, M., Hazama, Y., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.458 · Cited by 62
Jain, R., von Hurst, P. R., Stonehouse, W., Love, D. R., Higgins, C. M., & Coad, J. E. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.018 · Cited by 62
Knaś, M., Maciejczyk, M., Sawicka, K., Hady, H. R., Niczyporuk, M., Ładny, J. R., Matczuk, J., Waszkiel, D., Żendzian‐Piotrowska, M., & Zalewska, A. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12383 · Cited by 60
Loftus, H., Astell, K. J., Mathai, M. L., & Su, X. Q. (2015) · Nutrients · doi:10.3390/nu7115483 · Cited by 63
Hvid, T., Lindegaard, B., Winding, K. M., Iversen, P., Brasso, K., Solomon, T. P. J., Pedersen, B. K., & Højman, P. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0694-1 · Cited by 62
Chen, J., Mohler, E. R., Xie, D., Shlipak, M. G., Townsend, R. R., Appel, L. J., OJO, A. O., Schreiber, M. A., Nessel, L. C., Zhang, X., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv418 · Cited by 63
Assyov, Y. S., Gateva, A., Tsakova, A. D., & Kamenov, Z. A. (2016) · Endocrine Research · doi:10.3109/07435800.2016.1155598 · Cited by 63
Original paper Insulin resistance in severe acne vulgaris
Emiroğlu, N., Cengiz, F. P., & Kemeriz, F. (2015) · Advances in Dermatology and Allergology · doi:10.5114/pdia.2015.53047 · Cited by 62
White blood cell subtypes and risk of type 2 diabetes
Zhang, H., YANG, Z. K., Zhang, W., Niu, Y., Li, X., Qin, L., & Su, Q. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.029 · Cited by 62
Gidlund, E., von Walden, F., Venojärvi, M., Risérus, U., Heinonen, O. J., Norrbom, J., & Sundberg, C. J. (2016) · Physiological Reports · doi:10.14814/phy2.13063 · Cited by 64
Salvador, Â. C., Król, E., Lemos, V., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010013 · Cited by 62
Bertinato, J., Wang, K., & Hayward, S. (2017) · Nutrients · doi:10.3390/nu9030296 · Cited by 63
Zhang, Y., Wang, C., Zhou, J., Sun, A., Hueckstaedt, L. K., Ge, J., & Ren, J. T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.03.016 · Cited by 62
Serum Leptin Concentration is Associated with Incident Frailty in Older Adults
Lana, A., Valdés-Bécares, A., Soto, A. B., Rodríguez‐Artalejo, F., & López‐García, E. (2017) · Aging and Disease · doi:10.14336/ad.2016.0819 · Cited by 65
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics
Manco, M. (2017) · Children · doi:10.3390/children4080074 · Cited by 45
Ambient air pollution, adipokines, and glucose homeostasis: The Framingham Heart Study
Li, W., DORANS, K. S., Wilker, E. H., Rice, M. B., Kloog, I., Schwartz, J. D., Koutrakis, P., Coull, B. A., Gold, D. R., Meigs, J. B., et al. (2017) · Environment International · doi:10.1016/j.envint.2017.11.010 · Cited by 61
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis
Chouinard, V., Henderson, D. C., Man, C. D., Valeri, L., Gray, B. E., Ryan, K. P., Cypess, A. M., Cobelli, C., Cohen, B. M., & Öngür, D. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0045-1 · Cited by 62
Cahill, A. G., Haire-Joshu, D. L., Cade, W. T., Stein, R. I., Woolfolk, C., Moley, K. H., Mathur, A., Schechtman, K. B., & Klein, S. (2018) · Obesity · doi:10.1002/oby.22070 · Cited by 62
The physiologic and phenotypic significance of variation in human amylase gene copy number
Atkinson, F. S., Hancock, D., Petocz, P., & Brand-Miller, J. C. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy164 · Cited by 63
Oo, S. M., Misu, H., Saito, Y., Tanaka, M., Kato, S., Kita, Y., Takayama, H., Takeshita, Y., Kanamori, T., Nagano, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35067-2 · Cited by 66
Sasaki, N., Ozono, R., Higashi, Y., Maeda, R., & Kihara, Y. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015546 · Cited by 63
Behrouz, V., Dastkhosh, A., Hedayati, M., Sedaghat, M., Sharafkhah, M., & Sohrab, G. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00568-6 · Cited by 62
Decreased stature in gestational diabetes mellitus
Anastasiou, E., Alevizaki, M. K., Grigorakis, S. J., Philippou, G., Kyprianou, M., & Souvatzoglou, A. (1998) · Diabetologia · doi:10.1007/s001250051022 · Cited by 62
SCOTT, E. M., Greenwood, J. P., Vacca, G., Stoker, J. B., Gilbey, S. G., & Mary, D. (2002) · Clinical Science · doi:10.1042/cs1020523 · Cited by 59
Carmassi, F., Negri, F. D., Fioriti, R., Giorgi, A. D., Giannarelli, C., Fruzzetti, F., Pedrinelli, R., Dell’Omo, G., & Bersi, C. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2004.11.026 · Cited by 62
Nonalcoholic Steatohepatitis in Donors for Living Donor Liver Transplantation
Yamamoto, K., Takada, Y., Fujimoto, Y., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000250671.06456.3f · Cited by 62
Kondo, N., Nomura, M., Nakaya, Y., Ito, S., & Ohguro, T. (2005) · Circulation Journal · doi:10.1253/circj.69.452 · Cited by 62
Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers
Lee, G. A., Rao, M. N., Mulligan, K. M., Lo, J. C.-M., Aweeka, F. T., Schwarz, J., Schambelan, M., & Grünfeld, C. (2007) · AIDS · doi:10.1097/qad.0b013e32826fbc54 · Cited by 61
Forst, T. M., Lübben, G., Hohberg, C., Kann, P. H., Sachara, C., Gottschall, V., Friedrich, C., ROßKOPF, R., & Pfützner, A. (2005) · Microcirculation · doi:10.1080/10739680500253402 · Cited by 62
Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity.
Hanyu, O., Miida, T., Obayashi, K., Ikarashi, T., Soda, S., Kaneko, S., Hirayama, S., Suzuki, K., Nakamura, Y., Yamatani, K., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.034 · Cited by 77
Midaoui, A. E., Wu, R., & de Champlain, J. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00028 · Cited by 62
Leptin Gene Polymorphism Is Associated with Hypertension Independent of Obesity
Shintani, M., Ikegami, H., Fujisawa, T., Kawaguchi, Y., Ohishi, M., Katsuya, T., Higaki, J., Shimamoto, K., & Ogihara, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8595 · Cited by 62
Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria
Greenbaum, C. J., Cuthbertson, D. D., Krischer, J. P., & the Diabetes Prevention Trial of Type 1 Diabetes Study Group (2001) · Diabetes · doi:10.2337/diabetes.50.2.470 · Cited by 61
Lehmann, E. D., & Deutsch, T. (1995) · Medical Informatics · doi:10.3109/14639239509024284 · Cited by 64
Rezende, R. E. F., Duarte, S. M. B., Stefano, J. T., Roschel, H., Gualano, B., de Sá Pinto, A. L., Vezozzo, D. C. P., Carrilho, F. J., & Oliveira, C. P. (2016) · Menopause · doi:10.1097/gme.0000000000000647 · Cited by 62
Oh, E. S., Rhee, E.-J., Oh, K. W., Lee, W. Y., Baek, K. H., Yoon, K. H., Kang, M. I., Yun, E. J., Park, C. Y., Choi, M. G., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.005 · Cited by 61
Alvarez-Jimenez, L., Morales-Palomo, F., Moreno-Cabañas, A., Ortega, J. F., & Mora-Rodríguez, R. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175672 · Cited by 60
Lebenthal, Y., Levy, S., Sofrin-Drucker, E., Nagelberg, N., Weintrob, N., Shalitin, S., de Vries, L., Tenenbaum, A., Phillip, M., & Lazar, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00027 · Cited by 60
Enkhmaa, B., Shiwaku, K., Anuurad, E., Nogi, A., Kitajima, K., Yamasaki, M., Oyunsuren, T., & Yamane, Y. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.08.012 · Cited by 61
Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance
Quilliot, D., Alla, F., Böhme, P., Bruntz, J.-F., Hammadi, M., Dousset, B., Ziegler, O., & Zannad, F. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803022 · Cited by 61
Determinants of testosterone levels in human male obesity
Bekaert, M., Nieuwenhove, Y. V., Calders, P., Cuvelier, C. A., Batens, A.-H., Kaufman, J., Ouwens, D. M., & Ruige, J. B. (2015) · Endocrine · doi:10.1007/s12020-015-0563-4 · Cited by 63
Association between yogurt consumption, dietary patterns, and cardio-metabolic risk factors
Cormier, H., Thifault, É., Garneau, V., Tremblay, A., Drapeau, V., Përusse, L., & Vohl, M. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0878-1 · Cited by 64
Winnier, D. A., Fourcaudot, M. J., Norton, L., Abdul‐Ghani, M. A., Hu, S. L., Farook, V. S., Coletta, D. K., Kumar, S., Puppala, S., Chittoor, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119941 · Cited by 59
Hileman, C. O., Turner, R. L., Funderburg, N., Semba, R. D., & McComsey, G. A. (2015) · AIDS · doi:10.1097/qad.0000000000000885 · Cited by 61
Self-citationThyroid Hormones Crosstalk with Growth Factors: Old Facts and New Hypotheses
Candelotti, E., Vito, P. D., Ahmed, R. G., Luly, P., Davis, P. J., Pedersen, J. Z., Lin, H., & Incerpi, S. (2015) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152221501150710131534 · Cited by 61
Zaki, M. E., Kamal, S., Basha, W. A., Youness, E. R., Ezzat, W. M., El-Bassyouni, H. T., & Amr, K. S. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.07.002 · Cited by 61
Zhang, B., Shen, S., Gu, T., Hong, T., Liu, J., Sun, J., Wang, H., Bi, Y., & Zhu, D. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.005 · Cited by 64
Effects of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes
Rasouli, N., Brodsky, I. G., Chatterjee, R., Kim, S. H., Pratley, R. E., Staten, M. A., Pittas, A. G., Pittas, A. G., Brodsky, I. G., Ceglia, L., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab649 · Cited by 62
Babcock, M. C., DuBose, L. E., Witten, T. L., Stauffer, B. L., Hildreth, K. L., Schwartz, R. S., Kohrt, W. M., & Moreau, K. L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab715 · Cited by 64
Xuan, W., Liu, D., Zhong, J., Luo, H., & Zhang, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.949831 · Cited by 63
Zheng, R., Xin, Z., Li, M., Wang, T., Xu, M., Lu, J., Dai, M., Zhang, D., Chen, Y., Wang, S., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05819-x · Cited by 62
Nicoară, D.-M., Munteanu, A.-I., Scutca, A.-C., Mang, N., Jugănaru, I., Brad, G.-F., & Mărginean, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098414 · Cited by 62
Colantoni, A., Bucci, T., Cocomello, N., Angelico, F., Ettorre, E., Pastori, D., Lip, G. Y. H., Ben, M. D., & Baratta, F. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02263-6 · Cited by 65
Vassiliadi, D. A., Ntali, G., Vicha, E., & Tsagarakis, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03963.x · Cited by 61
Vayá, A., Rivera, L., Hernández‐Mijares, A., de la Fuente, M., Solá, E., Romagnoli, M., Alis, R., & Laíz, B. (2012) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2012-1544 · Cited by 61
Screening of polyphenolic plant extracts for anti‐obesity properties in Wistar rats
Boqué, N., Campión, J., de la Iglesia, R., et al. (2012) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.5884 · Cited by 61
Impaired atrial natriuretic peptide-mediated lipolysis in obesity
Rydén, M., Bäckdahl, J., Petrus, P., Thorell, A., Gao, H., Coué, M., Langin, D., Moro, C., & Arner, P. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.222 · Cited by 64
Karakosta, P., Georgiou, V., Fthenou, E., Papadopoulou, E., Roumeliotaki, T., Margioris, A. N., Castanas, E., Kampa, M., Kogevinas, M., & Chatzi, L. (2013) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12074 · Cited by 62
Vitamin D status and metabolic syndrome in Asian Indians
Majumdar, V., Nagaraja, D., & Christopher, R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.232 · Cited by 61
Cagnacci, A., Cannoletta, M., Caretto, S., Zanin, R., Xholli, A., & Volpe, A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181f31947 · Cited by 65
Caimari, A., Oliver, P., Rodenburg, W., Keijer, J., & Palou, A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.17 · Cited by 61
Factors Related to Declining Luteal Function in Women during the Menopausal Transition
Santoro, N., Crawford, S. L., Lasley, W. L., Luborsky, J. L., Matthews, K. A., McConnell, D. S., Randolph, J. F., Gold, E. B., Greendale, G. A., Korenman, S. G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2165 · Cited by 62
Ibrahim, S. M., El-Denshary, E. S., & Abdallah, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117516 · Cited by 66
Herzberg-Schäfer, S. A., Staiger, H., Heni, M., Ketterer, C., Guthoff, M., Kantartzis, K., Machicao, F. E., Stefan, N., Häring, H., & Fritsche, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014194 · Cited by 62
Corrêa, T. A. F., Rogero, M. M., Mioto, B. M., Tarasoutchi, D., Tuda, V. L., César, L. A. M., & Torres, E. A. F. S. (2013) · Nutrition · doi:10.1016/j.nut.2013.01.003 · Cited by 61
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome
Palomo, I. F., Contreras, A., Alarcón, M. A., Elba Leiva, M., Guzmán, L., Mujica, V., Icaza, G., Díaz, N. S., González, D. R., & Moore‐Carrasco, R. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.03.002 · Cited by 63
Tokushige, K., Hashimoto, E., Noto, H., Yatsuji, S., Taniai, M., Torii, N., & Shiratori, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0085-z · Cited by 61
Beydoun, H. A., Khanal, S., Zonderman, A. B., & Beydoun, M. A. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.07.014 · Cited by 64
Petta, S., Cammà, C., Marco, V. D., Alessi, N., Barbaria, F., Cabibi, D., Caldarella, R., Ciminnisi, S., Licata, A., Massenti, M. F., et al. (2008) · Hepatology · doi:10.1002/hep.22316 · Cited by 60
Chackrewarthy, S., Gunasekera, D., Pathmeswaren, A., Wijekoon, C. N., Ranawaka, U. K., Kato, N., Takeuchi, F., & Wickremasinghe, A. R. (2013) · ISRN Endocrinology · doi:10.1155/2013/320176 · Cited by 62
Lee, W., Almulaifi, A. M., Chong, K., Chen, S., Tsou, J. J., Ser, K., Lee, Y.-C., & Chen, J. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1603-0 · Cited by 62
Rare sugar d-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats
Hossain, A., Yamaguchi, F., Matsunaga, T., Hirata, Y., Kamitori, K., Dong, Y., Sui, L., Tsukamoto, I., Ueno, M., & Tokuda, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.135 · Cited by 63
Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis
Sobhonslidsuk, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3614 · Cited by 61
Tyynismaa, H., Raivio, T., Hakkarainen, A., Ortega‐Alonso, A., Lundbom, N. M. I., Kaprio, J. A., Rissanen, A., Suomalainen, A., & Pietiläinen, K. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1326 · Cited by 61
Corpeleijn, E., Petersen, L. V., Holst, C., Saris, W. H. M., Astrup, A. V., Langin, D., Macdonald, I. A., Martínez, J. A., Oppert, J., Polak, J., et al. (2009) · Obesity · doi:10.1038/oby.2009.377 · Cited by 61
Mokhlesi, B., Scoccia, B., Mazzone, T., & Sam, S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.12.024 · Cited by 61
do Amaral, C. L., Milagro, F. I., Curi, R., & Martínez, J. A. (2014) · BioMed Research International · doi:10.1155/2014/675021 · Cited by 66
Derosa, G., D’Angelo, A., Scalise, F., et al. (2007) · Heart and Vessels · doi:10.1007/s00380-007-0989-6 · Cited by 61
Alisi, A. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.965 · Cited by 61
Kato, T., Inoue, T., & Node, K. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-12 · Cited by 61
Shakeri-Manesch, S., Zeyda, M., Huber, J. C., Ludvik, B. H., Prager, G., & Stulnig, T. M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.160 · Cited by 61
Ashraf, A. P., Alvarez, J. A., Gower, B. A., Saenz, K. H., & McCormick, K. L. (2011) · Obesity · doi:10.1038/oby.2011.110 · Cited by 61
Silveira, L. S., Monteiro, P. A., Antunes, B. M., Seraphim, P. M., Fernandes, R. A., Christófaro, D. G. D., & Júnior, I. F. F. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-115 · Cited by 61
Zhang, Z., Kris‐Etherton, P. M., & Hartman, T. J. (2013) · Maternal and Child Health Journal · doi:10.1007/s10995-013-1382-y · Cited by 60
Zhang, Q., Zhu, L., Zheng, M., Fan, C.-H., Li, Y., Zhang, D., He, Y., & Yang, H. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.04.013 · Cited by 61
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
